Cargando…
Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients
BACKGROUND: The combination of immune checkpoint blockade (ICB) with standard therapies is becoming a common approach for overcoming resistance to cancer immunotherapy in most human malignancies including metastatic renal cell carcinoma (mRCC). In this regard, insights into the immunomodulatory prop...
Autores principales: | Rinchai, Darawan, Verzoni, Elena, Huber, Veronica, Cova, Agata, Squarcina, Paola, De Cecco, Loris, de Braud, Filippo, Ratta, Raffaele, Dugo, Matteo, Lalli, Luca, Vallacchi, Viviana, Rodolfo, Monica, Roelands, Jessica, Castelli, Chiara, Chaussabel, Damien, Procopio, Giuseppe, Bedognetti, Davide, Rivoltini, Licia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214860/ https://www.ncbi.nlm.nih.gov/pubmed/34185403 http://dx.doi.org/10.1002/ctm2.434 |
Ejemplares similares
-
BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R
por: Rinchai, Darawan, et al.
Publicado: (2021) -
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
por: Fortunato, Orazio, et al.
Publicado: (2022) -
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?
por: Mennitto, Alessia, et al.
Publicado: (2020) -
Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy
por: Grassi, Paolo, et al.
Publicado: (2016) -
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
por: Vergani, Elisabetta, et al.
Publicado: (2015)